Skip to main content
Premium Trial:

Request an Annual Quote

Genome Canada Fund Swells to C$111M. Spruce and Potatoes Rejoice!

NEW YORK, April 5 - Genome Canada today announced it has been awarded C$35.5 million, or $22.3 million, over the last three days, bringing to C$111.5 million the total current round of national investment in Canadian genomics projects.


In British Columbia, funded projects include:


·        C$3.2 million for bioinformatics research into mammalian gene expression, a project that pairs British Columbia Cancer Agency genomicists with researchers from the European Bioinformatics Institute and the Wellcome Trust.


·        C$5.3 million for  C. elegans tissue-expression profiling, to be carried out by BCCA, the University of British Columbia, Karolinska Institute researchers, and others.


·        C$5.9 million for a comprehensive atlas of gene expression in mouse development. This database will be created by researchers from BCCA, the University of British Columbia, and the US National Cancer Institute.


In the Atlantic states, efforts include:


·        C$2.1 million for research into the comparative and functional genomics of the spruce.


·        C$1.5 million for the Canadian Potato Genome Project.


Genome Canada announced another set of regional grants earlier last week, and plans to make additional awards on Monday.


Genome Canada, a non-for-profit organization, distributes government grants in order to foster and encourage genomics research. Last year, the organization awarded C$135 million to 22 projects.


The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.